Abstract:BackgroundBeta blockers form one of the mainstay therapies for myocardial infarction (MI). Preclinical studies have shown efficacy and safety of thyroid hormone (TH) treatment of cardiovascular disorders. Although THs interact with the sympathoadrenal system at various levels, crosstalk between TH signaling and β‐adrenergic signaling remains poorly understood. We compared pathophysiologic and TH‐adrenergic signaling changes between therapeutic doses of triiodothyronine (T3) and metoprolol (Met) in rats with MI.MethodsFemale Sprague‐Dawley rats aged 12 weeks underwent left anterior descending coronary artery ligation (MI) or sham surgeries. T3 (5 μg/kg/d) or Met (100 mg/kg/d) were given in drinking water immediately after surgery for 8 weeks. At terminal experiments, rats were subjected to morphological, functional, and molecular examination.ResultsT3 and Met significantly enhanced left ventricular (LV) fractional shortening (LVFS 21.4±2.6% and 21.1±3.7%, respectively) compared to untreated MI (17.9±1.2%) and decreased the incidence of inducible atrial tachyarrhythmia by 87.5% and 62.5% without producing untoward effects. Although both treatments showed efficacy, T3 but not Met showed statistically significant improvements compared to MI in arrhythmia duration, left atrial diameter (T3 vs MI 4.3±0.6 vs. 5.7±1.3 mm, p<0.05; Met 4.9±1.1), fibrosis (6.1±0.6%, 6.6±0.6% vs. 8.2±0.7%, T3, Met vs. MI, respectively) and aortic vasorelaxation responsiveness (pD2 6.97±0.22, 6.83±0.21 vs. 6.66±0.22, T3, Met vs MI, respectively). Quantitative PCR showed that T3 and Met attenuated expression of genes associated with inflammation and oxidative stress and restored expression of ion channels and contractile proteins compared to MI rats. Importantly, thyroid and β‐adrenergic signaling genes were favorably regulated by both treatments.ConclusionThese results support comparable efficacy of long‐term treatment with a physiological dose of T3 that is comparable to Met and suggest a potential therapeutic alternative to standard β‐blockade for patients intolerant to treatment with β‐blockers after MI.Support or Funding InformationThis work was supported by the National Heart, Lung, and Blood Institute of the NIH, Bethesda, MD, under Award Number R01HL103671 (AG). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We also acknowledged the National Natural Science Foundation of China (No. 81470485), Capital Clinical Featured Application Research Project (NO. z151100004015175) and CAMS Innovation Fund for Medical Sciences (CIFMS 2016‐I2M‐1‐009).This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Nanoscale organization of cardiac calcium channels is dependent on thyroid hormone status

Triiodothyronine Maintains Cardiac Transverse-Tubule Structure and Function.

Alteration of Myocardial Sarcoplasmic Reticulum Ca2+ Transport Protein Expression in Neonatal Hypothyroid Rats

Change of Electrocardiographic Manifestations of Neonates with Congenital Hypothyroidism and Its Clinical Significance

The Impact of Myosin Heavy Chain Isoforms on Contractile Behavior of the Heart

Cardiac hypertrophy and thyroid hormone signaling

Thyroid-stimulating Hormone Regulates Cardiac Function Through Modulating HCN2 Via Targeting Microrna-1A

Effect of hypothyroidism on contractile performance of isolated end-stage failing human myocardium

Thyroid Hormone Plays an Important Role in Cardiac Function: From Bench to Bedside

Cardiac Dysfunction Caused By Myocardium-Specific Expression Of A Mutant Thyroid Hormone Receptor

Thyroid Hormone Upregulates Cav1.2 Channels in Cardiac Cells via the Downregulation of the Channels' β4 Subunit

Low Thyroid Function Leads To Cardiac Atrophy With Chamber Dilatation, Impaired Myocardial Blood Flow, Loss Of Arterioles, And Severe Systolic Dysfunction

Reduced Sodium Currents in Isolated Mammalian Myocytes Treated with Chronic L‐thyroxine

Divergent Thyroid Hormone Levels in Plasma and Left Ventricle of the Heart in Compensated and Decompensated Cardiac Hypertrophy Induced by Chronic Adrenergic Stimulation in Mice

Novel Transcriptomic Interactomes of Noncoding RNAs in the Heart under Altered Thyroid Hormonal States

Crosstalk Between Thyroid Hormone Signaling and Β‐adrenergic Signaling in Myocardial Infarction

The role of thyroid hormone nuclear receptors in the heart: evidence from pharmacological approaches

The severity of valvular heart disease in euthyroid individuals is associated with thyroid hormone levels but not with TSH levels

Effects of Triiodothyronine Treatment in an Animal Model of Heart Failure with Preserved Ejection Fraction

Cardiac recovery from pressure overload is not altered by thyroid hormone status in old mice

Thyroid function effect on cardiac structure, cardiac function, and disease risk: Evidence of causal associations in European ancestry